Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC …

THP Nguyen, VB Kumar, VK Ponnusamy, TTT Mai… - Process …, 2021 - Elsevier
Over the past few decades, many of the phytochemicals have been shown to possess
extraordinary anticancer effects, clinical tested, approved as drugs, and currently in use. A
considerable number of phytochemicals either as a single-agent or combined with existing
anticancer drugs at pre-clinical and clinical levels have been evaluated to date. However,
the clinical trials on phytochemical evaluations against the world's top-ranked cancer,
NSCLC, was found to be a very little. Some of the phytochemicals that showed significant …
以上显示的是最相近的搜索结果。 查看全部搜索结果